Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty
      Description

      The purpose of this extension study is to determine if leuprolide acetate (11.25 mg and 30 mg) is safe in treating children with Central Precocious Puberty over a longer period of time (36 months).

      Conditions
      PrecociousLeuprolide AcetateLuteinizing Hormone (LH)Gonadotrophin-releasing Hormone Agonist (GnRHa)Tanner StagingDepot FormulationSuppression of LHCentral Precocious Puberty (CPP)Gonadotrophin-releasing Hormone (GnRH)LupronGnRH AnalogPediatrics Central Precocious Puberty
      Talk to us